Weiss, T., Schneider, H., Silginer, M., Steinle, A., Pruschy, M., Polić, B. ... Roth, P. (2018). NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma. Clinical Cancer Research, 24. (4), 882-895. doi: 10.1158/1078-0432.CCR-17-1766
Weiss, Tobias, et al. "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma." Clinical Cancer Research, vol. 24, br. 4, 2018, str. 882-895. https://doi.org/10.1158/1078-0432.CCR-17-1766
Weiss, Tobias, Hannah Schneider, Manuela Silginer, Alexander Steinle, Martin Pruschy, Bojan Polić, Michael Weller i Patrick Roth. "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma." Clinical Cancer Research 24, br. 4 (2018): 882-895. https://doi.org/10.1158/1078-0432.CCR-17-1766
Weiss, T., et al. (2018) 'NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma', Clinical Cancer Research, 24(4), str. 882-895. doi: 10.1158/1078-0432.CCR-17-1766
Weiss T, Schneider H, Silginer M, Steinle A, Pruschy M, Polić B, i sur.. NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma. Clinical Cancer Research [Internet]. 15.02.2018. [pristupljeno 30.08.2024.];24(4):882-895. doi: 10.1158/1078-0432.CCR-17-1766
T. Weiss, et al., "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma", Clinical Cancer Research, vol. 24, br. 4, str. 882-895, Veljača 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:482828. [Citirano: 30.08.2024.]